Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Nike
NKE
|
+$631M |
| 2 |
PNC Financial Services
PNC
|
+$614M |
| 3 |
XYZ
Block, Inc.
XYZ
|
+$328M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$275M |
| 5 |
FedEx
FDX
|
+$236M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.16B |
| 2 |
Meta Platforms (Facebook)
META
|
+$595M |
| 3 |
AbbVie
ABBV
|
+$489M |
| 4 |
Crown Castle
CCI
|
+$326M |
| 5 |
McDonald's
MCD
|
+$325M |
Sector Composition
| 1 | Technology | 20.85% |
| 2 | Consumer Discretionary | 16.57% |
| 3 | Financials | 13.84% |
| 4 | Healthcare | 12.56% |
| 5 | Communication Services | 11.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
BP
BP
$88.5B
| $41.9M | 0.04% |
1,113,377
+229,361
| +26% | +$8.64M |
|
|
AGR
277
DELISTED
Avangrid, Inc.
AGR
| $41.8M | 0.04% |
817,523
| – | – |
|
|
VIAB
278
DELISTED
Viacom Inc. Class B
VIAB
| $41.6M | 0.04% |
1,340,742
-2,786
| -0.2% | -$86.5K |
|
|
CLR
279
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $41.2M | 0.04% |
698,764
-933,118
| -57% | -$55M |
|
280
CoStar Group
CSGP
$36.9B
| $41.1M | 0.04% |
1,131,900
-132,380
| -10% | -$4.8M |
|
281
Nektar Therapeutics
NKTR
$900M
| $40.9M | 0.04% |
25,665
+8,771
| +52% | +$14M |
|
282
Pebblebrook Hotel Trust
PEB
$1.39B
| $40.7M | 0.04% |
1,185,301
-12,371
| -1% | -$425K |
|
|
AET
283
DELISTED
Aetna Inc
AET
| $40.3M | 0.04% |
238,504
-136,030
| -36% | -$23M |
|
284
MSC Industrial Direct
MSM
$5.12B
| $40.1M | 0.04% |
436,704
+194,262
| +80% | +$17.8M |
|
285
CSX Corp
CSX
$60.9B
| $40M | 0.04% |
2,151,609
-17,283
| -0.8% | -$321K |
|
|
HRC
286
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $39.9M | 0.04% |
+459,077
| New | +$39.9M |
|
287
Lam Research
LRCX
$146B
| $39.5M | 0.04% |
1,946,120
-544,250
| -22% | -$11.1M |
|
288
Terex
TEX
$3.49B
| $39.5M | 0.04% |
1,054,706
+1,548
| +0.1% | +$57.9K |
|
289
JELD-WEN Holding
JELD
$562M
| $38.9M | 0.04% |
1,271,686
+6,602
| +0.5% | +$202K |
|
290
Exact Sciences
EXAS
$10.6B
| $38.8M | 0.04% |
962,164
+443,575
| +86% | +$17.9M |
|
291
Keurig Dr Pepper
KDP
$37.5B
| $38.4M | 0.04% |
+324,194
| New | +$38.4M |
|
|
EPZM
292
DELISTED
Epizyme, Inc
EPZM
| $38.1M | 0.04% |
2,148,026
+272,498
| +15% | +$4.84M |
|
|
NEWR
293
DELISTED
New Relic, Inc.
NEWR
| $37.9M | 0.04% |
511,456
-2,837
| -0.6% | -$210K |
|
|
PFPT
294
DELISTED
Proofpoint, Inc.
PFPT
| $37.8M | 0.04% |
332,164
-7,177
| -2% | -$816K |
|
295
Texas Roadhouse
TXRH
$11.1B
| $37.6M | 0.04% |
650,314
-1,824
| -0.3% | -$105K |
|
296
Olin
OLN
$3.07B
| $37M | 0.04% |
1,217,553
-947,564
| -44% | -$28.8M |
|
|
CLVS
297
DELISTED
Clovis Oncology, Inc.
CLVS
| $36.8M | 0.04% |
697,576
+93,904
| +16% | +$4.96M |
|
|
SEMG
298
DELISTED
SEMGROUP CORPORATION
SEMG
| $36.6M | 0.04% |
1,708,323
-34,855
| -2% | -$746K |
|
299
Oracle
ORCL
$870B
| $36.5M | 0.04% |
797,868
-533,089
| -40% | -$24.4M |
|
300
Premier
PINC
$2.21B
| $36.4M | 0.04% |
1,161,502
+11,034
| +1% | +$345K |
|